WILMINGTON, Delaware --A federal jury of eight will continue on Friday deliberations begun late Thursday on Oxford Gene Technology's allegation that Affymetrix's (AFFX) GeneChip product infringes on ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics ® Corporation for $15 ...

SAN DIEGO & SANTA CLARA, Calif., Jan 10, 2008 - Affymetrix and Illumina, Inc. (NASDAQ:ILMN) announced today that they have entered into a settlement agreement to resolve their patent litigation. Under ...

Shares jump after the company's board approves a buyout offer from Thermo Fisher Scientific. So what: This transaction should help to grow Thermo's footprint in the red-hot area of biogenetic analysis ...

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2012. Total revenue for the quarter was $66.4 million, including approximately $1.4 million in revenue ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) announced the launch of the new OncoScan™ FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor ...

Can a single word in a 35,000-word merger agreement cause a buyer to lose a deal to a higher bidder? In the case of Thermo Fisher Scientific Inc.’s pending buyout of Affymetrix Inc., it’s possible.

Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...

Affymetrix' management team will host a conference call on April 27, 2011 at 2:00 p.m. PT to review its operating results for the first quarter of 2011. A live webcast can be accessed by visiting the ...

There's no foolproof way to know the future for Affymetrix (NAS: AFFX) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock ...